A股異動丨恆信東方大漲近9% 中國虛擬現實大會即將召開
格隆匯11月19日丨恆信東方(300081.SZ)大漲近9%,報9.63元,總市值51億元。第十九屆中國虛擬現實大會(ChinaVR 2019)將於2019年11月21日至24日在深圳大學城會議中心舉行,500餘名專家學者將齊聚一堂,共同研討相關領域最新理論、技術成果與行業應用。同期將舉辦虛擬現實產學研大會、虛擬現實產業創新應用展、虛擬現實內容創意與技術挑戰賽等。恆信東方業務範圍主要包括CG/VR內容生產、兒童產業鏈開發運營、LBE(Location Based Entertainment)城市新娛樂、互聯網視頻應用產品及服務、移動信息產品的銷售與服務業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.